Hypersensitivity Pneumonitis and the Immune System

Trial Objective

Hypersensitivity Pneumonitis and the Immune SystemThe goal of this study is to learn more about how some white blood cells cause the inflammation associated with Hypersensitivity Pneumonitis, a lung disorder caused by inhaled dust, fungus, molds or chemicals. By better understanding this lung disorder at a cellular level, researchers can identify new treatments and medications.

Enrollment

New enrollment for this trial is temporarily paused

Who Can Participate

Adults 18 to 80 years of age who have hypersensitivity pneumonitis, but have not been on any treatment for at least three months and have not smoked cigarettes or marijuana in the last six months.

Age: 18-80    Gender: Any Gender


Estimated Time Commitment

Approximately 9 hours over 3 study visits

The first visit takes about one hour. The second visit takes approximately four hours and includes testing. The third visit takes approximately four hours and includes additional testing.



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Peggy Mroz

Peggy Mroz
303.398.1730

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Pulmonary Fibrosis Foundation

Co-Investigators


Request More Information

Due to concerns around COVID-19 and our focus on helping to meet this momentous challenge, we have temporarily paused enrollment for all trials requiring an in-person visit. Please feel free to request additional information about any of the trials we have posted and we will get back to you when enrollment resumes. For more resources and information on COVID-19 please visit our special coronavirus website at www.njhealth.org/coronavirus.


*
*
*
*